Abstract: The invention relates to a compound selected from the group consisting of desethylamiodarone and pharmaceutically acceptable salts, hydrates and solvates thereof, as well as pharmaceutical composition comprising the compound together with a pharmaceutically acceptable excipient, vehicle or carrier, for use in the treatment of cancer.
Type:
Grant
Filed:
November 29, 2016
Date of Patent:
February 6, 2018
Assignee:
Pésci Tudományegyetem
Inventors:
Zita Bognár, Balázs Sümegi, Ferenc Gallyas, Jr., Kálmán Tóth